No Data
No Data
Institutional Investors May Overlook Bristol-Myers Squibb Company's (NYSE:BMY) Recent US$5.9b Market Cap Drop as Long-term Gains Remain Positive
9 Health Care Stocks With Whale Alerts In Today's Session
Bristol Myers Squibb Terminates Agreements With Immatics Due To Ongoing Portfolio Prioritization Efforts Within BMS For Allogeneic Programs; Collaboration With BMS Under The 2019 Multi-Target TCR-T Strategic Collaboration Agreement Remains Ongoing
Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
Bristol-Myers Squibb Analyst Ratings
Jefferies Upgrades Bristol-Myers Squibb(BMY.US) to Buy Rating, Raises Target Price to $70